This compound is a carbamate derivative used as a pharmaceutical reference standard. Its structure features two carbamate groups and an ether linkage, and it is commonly employed in analytical testing and quality control for pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 25462-39-9
Iohexol EP Impurity E
pharmaceutical reference standard
2-Chloroadenosine 5'-Monophosphate Ditriethylamine Salt
pharmaceutical reference standard
(2S)-3-methyl-2-[2,2,3,3,4,4,5,5,5-nonadeuteriopentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
pharmaceutical reference standard
Valsartan impurity E
pharmaceutical reference standard
Sparsentan
dual endothelin and angiotensin receptor antagonist
3-Isoquinolinamine
active pharmaceutical ingredient
Lirafugratinib
orally bioavailable FGFR2 inhibitor
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Active pharmaceutical ingredient
[2-(carbamoyloxymethyl)-2-methylpent-4-enyl] carbamate
JVAXHLUHJFLHDW-UHFFFAOYSA-N
CC(CC=C)(COC(=O)N)COC(=O)N